Evidence map›Paper›PMID 36059402›Full record

ArticleComputational intelligence and neuroscience2022

The Protective Effect of Ursolic Acid on Unilateral Ureteral Obstruction in Rats by Activating the Nrf2/HO-1 Antioxidant Signaling Pathway.

Jun Pei, Moudong Wu, Shuyu Cai, Jinpu Peng, Xiong Zhan, Dan Wang, Wei Wang, Nini An

Open access · hybridAbstract read
In one paragraph

Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Advances in the Targeted Drug Delivery System for Renal Fibrosis.International journal of nanomedicine · 2026
    Review
  3. Article
  4. Review
  5. Detection of Ferroptosis by Immunohistochemistry and Immunofluorescence.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jun PeiDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Moudong WuDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Shuyu CaiDepartment of Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Jinpu PengDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Xiong ZhanDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Dan WangDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Wei WangDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Nini AnDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.ORCID https://orcid.org/0000-0001-8035-7496
Guizhou Provincial People's Hospital · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal interstitial fibrosis is a common pathological feature of a variety of kidney diseases that progress to end-stage renal disease. The excessive deposition of extracellular matrix (ECM) is a typical pathological change of renal interstitial fibrosis. The production of reactive oxygen species in renal tubules is an important factor leading to the development of renal interstitial fibrosis. Ursolic acid (UA) is a natural pentacyclic triterpene carboxylic acid compound widely found in plants. It has anti-inflammatory, antioxidant, and antitumor cell proliferation effects. It can reduce the development of fibrosis by inhibiting the oxidative stress response of the liver; there is currently no relevant research on whether UA can protect the renal interstitial fibrosis by resisting oxidative stress in the kidneys. In this study, our purpose is to investigate the effect of ursolic acid on renal interstitial fibrosis after unilateral ureteral obstruction (UUO) in rats and its related mechanisms. We established a UUO model by surgically ligating the right ureter of the rat and instilling UA preparation (40 mg/kg/d) through the stomach after the operation, once a day for 7 days. We found that UUO caused impaired renal function, increased pathological damage, increased renal interstitial fibrosis, increased apoptosis, increased oxidative stress damage, and decreased antioxidants. However, after UA preparations were given, the abovementioned damage was significantly improved. At the same time, we also found that UA preparations can significantly increase the relative expression of Nrf2/HO-1 signaling pathway in kidney tissue after UUO. In order to further verify whether the Nrf2/HO-1 signaling pathway is involved in the development of renal interstitial fibrosis, we injected zinc protoporphyrin (ZnPP, 45 umol/kg), a specific blocker of the Nrf2/HO-1 signaling pathway, into the intraperitoneal cavity after UUO in rats and before the gastric perfusion of ursolic acid preparations. Subsequently, we observed that the protective effect of UA on renal interstitial fibrosis after UUO in rats was reversed. Combining all the research results, we proved that UA has a protective effect on renal interstitial fibrosis after UUO in rats, which may be achieved by activating the Nrf2/HO-1 signaling pathway.

Indexed as

Kidney DiseasesUreteral ObstructionAnimalsAntioxidantsFibrosisHeme Oxygenase (Decyclizing)NF-E2-Related Factor 2Oleanolic AcidRatsSignal TransductionUrsolic AcidAntioxidantsHeme Oxygenase (Decyclizing)Hmox1 protein, ratNF-E2-Related Factor 2Oleanolic AcidUrsolic Acid

Identifiers

PMID36059402
PMCPMC9436538
OpenAlexW4293080059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.